Medical outpatient buildings are starting to look like the “adult in the room” of commercial real estate: steady, in-demand, and largely insulated from the forces dragging down conventional office.

What The Underlying Data Is Telling Us

Over the last decade, dollar volume in medical outpatient transactions has exploded—from $29 billion in 2016 to $154 billion in 2025. At the same time, the number of deals has fallen from a high of 4,821 in 2021 to 2,803 in 2025. That combination usually points to one thing: the market is consolidating into fewer, larger trades—more portfolios, more institutional-scale assets, more “big check” buyers.

This matters because it suggests the sector isn’t just surviving—it’s maturing into a capital markets favorite.

Why MOBs Are Separating From “Office”

Traditional office has been squeezed by demand uncertainty, new workplace patterns, and corporate space reductions. Medical outpatient doesn’t rely on that demand engine. It’s tethered to service delivery—clinics, imaging, specialty practices, outpatient surgery—things that still require physical locations in convenient, patient-friendly settings.

The performance gap is clear across a few measures from 2023 to 2025:

• New supply: general office deliveries fell 54.1%, while medical outpatient deliveries dipped only 5.3%.
• Rents: office rents declined 3.4%, while medical outpatient rents rose 6.2%.
• Occupancy: by the end of 2025, office averaged 80.2% occupied versus 92.3% for medical outpatient.

In other words: one “office” category is fighting for relevance; the other is expanding on fundamentals.

The Labor Market is Reinforcing Demand

Healthcare staffing needs are rising fast. Job postings in medical and social assistance more than doubled from mid-2020 to mid-2025, climbing from 88,630 to 205,437. That kind of hiring pressure is a real-world indicator that systems, clinics, and care networks are building capacity—often through outpatient expansion. Wage growth follows, too, as employers compete for specialized talent.

This is important because real estate demand tied to expanding service lines tends to be stickier than demand tied to corporate headcount that can be cut quickly.

Bigger Cities are Acting Like Demand Anchors

Among major metros, New York City sits at the top of the inventory list with 77.3 million square feet of medical outpatient space and 739,605 square feet of net absorption in the second half of 2025. Los Angeles and Chicago follow with 60.7 million and 47.5 million square feet, respectively. A few markets posted modest negative absorption, but the national picture still reads as healthy demand with some local softness.

That pattern—strong overall demand but uneven market-to-market—should sound familiar to anyone watching multifamily or industrial cycles.

Investors Are Bidding More Aggressively

Cap rates compressed from 7.47% at the end of 2024 to 6.49% by year-end 2025. That’s the market’s way of saying: buyers are treating the income stream as more reliable and are willing to accept lower yields to get it.

The buyer mix also signals broad appeal:

• Private buyers: 51.1% of acquisitions
• Public REITs: 26.3%
• Institutional buyers: 9%
• Users/owner-occupiers: just over 2%

So this isn’t a niche corner of the market anymore—it’s attracting a wide range of capital, with private money still doing the most volume.

What’s Missing (and what you should pressure-test)

The headline metrics are strong, but they can hide real risk:

• Tenant strength varies wildly. A building leased to a major health system is not the same as one filled with small practices. Credit quality, lease guarantees, and renewal probability matter more than the “MOB” label.
• Reimbursement exposure is real. Outpatient demand is durable, but provider economics still flow through payer mix and reimbursement rates. That’s a business risk that eventually becomes a leasing risk.
• New supply can cluster. National supply numbers don’t capture what happens when multiple outpatient projects land in the same corridor and compete for the same physicians and patient base.
• Portfolio trades can concentrate risk. Fewer, larger transactions can mean buyers are taking bigger bets on a handful of markets, operators, or specialties.

Implications

If you’re allocating capital today, medical outpatient is sending a clear message: this is where “office-like” product still behaves like a necessity asset. For developers and owners, the opportunity is real—but the edge will come from disciplined site selection, strong tenant underwriting, and an honest look at how healthcare economics affect real estate performance.

The bigger takeaway: the office market isn’t one market anymore. Medical outpatient is proving it.

Source:  GlobeSt.